Cognitive dysfunction in adolescents with chronic fatigue: a cross-sectional study by Sulheim, Dag et al.
Cognitive dysfunction in adolescents with chronic
fatigue: a cross-sectional study
Dag Sulheim,1,2 Even Fagermoen,3,4 Øyvind Stople Sivertsen,5 Anette Winger,6
Vegard Bruun Wyller,1,7,8 Merete Glenne Øie9,10
▸ Additional material is
published online only. To view
please visit the journal online
(http://dx.doi.org/10.1136/
archdischild-2014-306764).
For numbered afﬁliations see
end of article.
Correspondence to






Received 11 May 2014
Revised 25 February 2015
Accepted 26 February 2015
Published Online First
19 March 2015
To cite: Sulheim D,
Fagermoen E, Sivertsen ØS,
et al. Arch Dis Child
2015;100:838–844.
ABSTRACT
Objective To compare cognitive function in
adolescents with chronic fatigue with cognitive function
in healthy controls (HC).
Study design Cross-sectional study.
Setting Paediatric department at Oslo University
Hospital, Norway.
Participants 120 adolescents with chronic fatigue
(average age 15.4 years; range 12–18) and 39 HC
(average age 15.2 years; range 12–18).
Methods The adolescents completed a neurocognitive
test battery measuring processing speed, working
memory, cognitive inhibition, cognitive ﬂexibility, verbal
learning and verbal memory, and questionnaires
addressing demographic data, depression symptoms,
anxiety traits, fatigue and sleep problems. Parents
completed the Behaviour Rating Inventory of Executive
Function (BRIEF), which measures the everyday executive
functions of children.
Results Adolescents with chronic fatigue had impaired
cognitive function compared to HC regarding processing
speed (mean difference 3.3, 95% CI 1.1 to 5.5,
p=0.003), working memory (−2.4, −3.7 to −1.1,
p<0.001), cognitive inhibition response time (6.2, 0.8 to
11.7, p=0.025) and verbal learning (−1.7, −3.2 to
−0.3, p=0.022). The BRIEF results indicated that
everyday executive functions were signiﬁcantly worse in
the chronic fatigue group compared to the HC (11.2, 8.2
to 14.3, p<0.001). Group differences remained largely
unaffected when adjusted for symptoms of depression,
anxiety traits and sleep problems.
Conclusions Adolescents with chronic fatigue had
impaired cognitive function of clinical relevance,
measured by objective cognitive tests, in comparison to
HC. Working memory and processing speed may
represent core difﬁculties.
INTRODUCTION
Fatigue among adolescents is common,1 and disab-
ling fatigue at age 13 of more than 3 months’ dur-
ation was recently reported with an estimated
prevalence of 2.2%.2 Adolescent chronic fatigue
syndrome (CFS), with an estimated prevalence of
0.1–1.0%,3 4 is an important cause of disability and
has a negative impact on quality of life, school
attendance and social and family functioning.3 5
Among the many case deﬁnitions of CFS, that pro-
posed by the Centers for Disease Control and
Prevention (CDC) in 19946 is most often used in
studies.7 More than 80% of individuals with CFS
report cognitive problems such as difﬁculty think-
ing, impairment of short-term memory, inability to
concentrate, and difﬁculties with word-ﬁnding,
information processing and planning/organising
thoughts.8 9
Studies of cognitive dysfunction in CFS-affected
children and adolescents report impaired interfer-
ence control,10 attention,11 12 immediate recall,
auditory learning,11 motor skills and spatial
working memory.12 However, the studies included
few patients (n=19–34), and the results should be
conﬁrmed by larger studies.
Executive functions (EF; higher-order cognitive
functions, related to the control of thought, action
and emotion) are essential to cope with the chal-
lenges of everyday life and school. Inhibition (inter-
ference control), working memory and cognitive
ﬂexibility (switching attention) have been proposed
as essential subcomponents of EF.13 The Behaviour
Rating Inventory of Executive Function (BRIEF),
which was designed to improve the ecological val-
idity of EF assessment,14 to our knowledge has not
been used in studies of cognition in adolescent
chronic fatigue.
Anxiety and depression symptoms are frequent
in CFS15 16 and may be associated with cognitive
impairment.17 18 Sleep problems are among the
most prevalent symptoms in adolescent CFS.3 9
A possible association between sleep problems and
cognitive abilities in young people with CFS
remains to be investigated. As anxiety, depression
symptoms and sleep problems are associated with
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What is already known on this topic?
▸ Adolescents with chronic fatigue syndrome
(CFS) have extensive school absence.
▸ Depression symptoms, anxiety and sleep
problems are frequent in adolescents with CFS.
▸ Adolescents with CFS frequently report
cognitive problems.
What this study adds?
▸ Adolescents with chronic fatigue perform worse
than healthy peers in several cognitive
functions.
▸ The cognitive impairments are of clinical
importance.
▸ Anxiety traits and depression symptoms do not
explain the cognitive impairments in adolescent
chronic fatigue.
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both CFS and cognition, they may be regarded as possible mod-
erators of cognitive function in CFS.
The primary aim of this study was to characterise cognitive
function (using both objective and inventory-based measures) in
a large group of adolescents with chronic fatigue and in healthy
controls (HC) and compare the results. The secondary aim was
to explore the possible contributing impact of anxiety traits,
depression symptoms and sleep problems on cognitive function.
METHODS
Design
This study is part of the NorCAPITAL project (The Norwegian
Study of Chronic Fatigue Syndrome in Adolescents:
Pathophysiology and Intervention Trial; ClinicalTrials ID:
NCT01040429), which has a cross-sectional design and is a
double-blind, randomised, placebo-controlled study. It was con-
ducted at the Department of Paediatrics, Oslo University
Hospital, Norway, which is a national referral centre for young
CFS patients. The current study is based on cross-sectional data
collected from March 2010 to May 2012 during a clinical
in-hospital day. The following week, participants completed the
questionnaires and returned them by mail. Parents completed
the BRIEF. Cognitive testing was performed by the study physi-
cians (DS and EF) and supervised by an experienced neuro-
psychologist (MGØ). All participants received a gift-card worth
NOK 200. Informed, written consent was obtained from all par-
ticipants and from parents/next-of-kin, if required. The study
was conducted in accordance with the Helsinki Declaration of
the World Medical Assembly and was approved by the
Norwegian National Committee for Ethics in Medical Research.
Participants
All hospital paediatric departments (20), primary care paediatri-
cians and general practitioners in Norway were invited to refer
patients aged 12–18 years with long-lasting fatigue to our
department. For inclusion in the present study, we required at
least 3 months of unexplained, disabling chronic/relapsing
fatigue of new onset. Eligibility was based upon the referral
information, and inclusion was decided after a thorough
evaluation by the study physicians (DS or EF). A group of HC
matched by age and gender distribution to the chronic fatigue
group was recruited from local schools. Table 1 displays inclu-
sion and exclusion criteria.
Cognitive assessment
The cognitive tests and assessments (see table 2 for descriptions
of the tests used) were conducted between 10 a.m. and 12 p.m.,
and lasted for approximately 40 min.
A cognitive inhibition contrast measure was calculated to
control for potential difﬁculties with processing speed. From
the time taken to complete Condition 3 (inhibition) of the
Color Word Interference Test of the Delis–Kaplan Executive
Function System, we subtracted the mean sum score of the pre-
ceding tasks of Condition 1 (colour naming) and Condition 2
(reading): (Condition 3−[Condition 1+Condition 2]/2).
The Norwegian version of the BRIEF19 was completed by
parents within a week of the adolescent tests. The BRIEF has
shown high internal consistency.20 It is composed of eight clin-
ical scales, two broad indices and one overall score, the global
executive composite (GEC).
Questionnaires
The Karolinska Sleep Questionnaire (KSQ) addresses sleep pro-
blems during the preceding month. Scores range from 1 to 6,
with a lower score implying poorer sleep. The KSQ has been
used in epidemiological studies of fatigue.21
The Mood and Feelings Questionnaire (MFQ) measures self-
reported depression.22 The Spielberger State-Trait Inventory
(STAI-T) measures self-rated anxiety traits.23 Higher scores indi-
cate more problems on both scales.
Statistical analysis
Statistical software (IBM SPSS Statistics V.20; Armonk,
New York, USA) was used for data analysis. χ2, Student’s t or
Mann–Whitney tests were used to compare the chronic fatigue
and HC groups.
Participants lacking all data in an inventory or a questionnaire
component variable were excluded from analysis of that
Table 1 Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
Patients with chronic fatigue Persisting or constantly relapsing fatigue lasting
3 months or more
Another current disease process or demanding life event
that might explain the fatigue
Functional disability resulting from fatigue that prevents normal
school attendance
Another chronic disease









Known hypersensitivity towards clonidine or inert substances
(lactose, sucrose) in capsula
Abnormal ECG (apart from ectopic beats)
Supine heart rate <50 bpm
Supine systolic blood pressure <85 mm Hg
Upright systolic blood pressure fall >30 mm Hg
Healthy control subjects Age ≥12 and <18 years Another chronic disease
Permanent use of drugs (including hormones)
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variable. If one or two of several items in a component variable
were missing, this value was imputed, based upon the mean
value of all other participants in that group.
Multiple linear regression analyses were applied to identify a
possible contribution effect by depression symptoms, anxiety
traits or sleep problems on the group differences in cognitive
function. All tests were two-sided, and p≤0.05 was considered
statistically signiﬁcant. We applied no correction for multiple
comparisons. Effect size was classiﬁed as small (0.2), medium
(0.5) or large (0.8), according to Cohen.24
We regarded effect sizes of more than 0.5 to be of clinical
interest. With 120 participants in the chronic fatigue group and
39 HC, the power to detect an effect size of more than 0.5 was
about 80%.
RESULTS
A total of 120 adolescents with chronic fatigue (mean age
15.4 years) and 39 HC (mean age 15.2 years) were included. All
but ﬁve in the chronic fatigue group were drug naive on inclu-
sion and testing (three used melatonin, one used thyroxine on a
regular basis, and one had taken paracetamol the day before par-
ticipation). All members of the HC group were drug naive.
Background characteristics and results from the questionnaires
are given in table 3.
The chronic fatigue group performed worse than the HC
group for processing speed (p=0.003), working memory
(p<0.001), cognitive inhibition response time (p=0.025) and
verbal learning (p=0.022), as well as on the BRIEF GEC score
(p<0.001) (table 4). The groups did not differ with regard to
errors or the contrast measure of cognitive inhibition. When
adjusted for working memory in the analysis of verbal learning,
the group difference disappeared.
In the HC group, the mean results of the cognitive tests and
the BRIEF were both within 1 SD of standardised norms25 26
and HC results in other studies in Norway.27 28 In the chronic
fatigue group, 28–65% performed more than 1 SD worse than
the norms (see supplementary online eTable 1).
The group differences in processing speed, cognitive inhib-
ition response time, verbal learning, and the BRIEF, remained
largely unaffected when adjusted for symptoms of depression,
anxiety traits or sleep problems in the multiple regression
models. The group differences in working memory remained
statistically signiﬁcant when adjusted for depression symptoms
or anxiety traits, but lost statistical signiﬁcance when adjusted
for sleep problems (KSQ). The regression coefﬁcients and R2
values are given in table 5.
The results from the analyses of the subgroup (deﬁned by the
CDC criteria) were not signiﬁcantly different from those for the
chronic fatigue group (tables 3–5 and supplementary online
eTables 1 and 2).
DISCUSSION
This study demonstrates that adolescents with chronic fatigue,
deﬁned as persisting or relapsing fatigue of more than
3 months’ duration, perform worse than HC on measures of
processing speed, working memory, verbal learning and cogni-
tive inhibition response time, but not on cognitive ﬂexibility or
delayed recall. According to parents’ observations, their children
with chronic fatigue have more problems with everyday EF.
Adolescents with chronic fatigue also report more sleep pro-
blems, symptoms of depression and anxiety traits, but none of
these fully explain the group differences in cognitive measures.
An analysis of a subgroup that met the CDC criteria for CFS,
shows results similar to those for the study’s main chronic
fatigue group.
Comparison with the literature
To our knowledge, our study of cognitive problems in adoles-
cents with chronic fatigue has included more patients than any
other study of similar groups. Reduced processing speed and
Table 2 Cognitive tests and assessments
Cognitive function Test name Test description Test score
Working memory WISC-IV
Digit span forward and
backward
Repeat numbers verbatim or in reverse order as stated by the
administrator
Sum score 0–32
Higher score implies better working memory
Processing speed D-KEFS CWIT
Conditions 1 and 2
Name the colours of different bars (Condition 1) and read written colour
names aloud in that colour (Condition 2).
Response time (s) on each condition
Mean of results from the two conditions
Higher score implies slower processing speed
Cognitive inhibition D-KEFS CWIT
Condition 3
Read aloud the colour of the names of colours printed in a different
colour
Response time (s)
Higher score implies more difficulties with
the task
Number of errors
Higher score implies more errors
Cognitive flexibility D-KEFS CWIT
Condition 4
Switch between reading colour words and naming dissonant ink colours Response time (s)




The administrator reads 12 words aloud.
The examinee repeats as many words as possible in three trials
Sum score of words remembered in all three
trials together (0–36)





Examinee recalls words after a 20 min delay Number of words remembered (0–12)






Parents score 86 statements regarding the daily executive functioning of
their child
Score gives an overall measure of executive
function
Higher score implies higher degree of
impairment
BRIEF, Behaviour Rating Inventory of Executive Function; D-KEFS CWIT, Delis–Kaplan Executive Function System Color Word Interference Test; HVLT-R, Hopkins Verbal Learning
Test-Revised; WISC-IV, Wechsler Intelligence Scale for Children, 4th ed.
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reduced working memory showed the most signiﬁcant group
differences. Kawatani et al12 found reduced working memory
and reduced processing speed in children with CFS. However,
they used a spatial working memory task, while we used a
verbal working memory task. They also used a different task for
measuring processing speed. A direct comparison between these
studies is therefore questionable.
In contrast to our results, Haig-Ferguson et al11 did not dem-
onstrate reduced processing speed or reduced working memory.
A possible explanation for the contrasting results could be insuf-
ﬁcient statistical power due to the small number of participants
in the previous study. Furthermore, that study did not include a
healthy comparison group and the patients were about 2 years
younger than our participants.
Table 3 Demographic and clinical characteristics of the study participants
Characteristics














Female (%) 86 (72) 64 (72) 28 (72) 0.98 0.91
Age
Mean (SD) 15.4 (1.6) 15.3 (1.6) 15.2 (1.6) 0.57 0.79
Age range, years 12–18 12–18 12–18
BMI
Mean (SD, Z score) 21.5 (4.2, 0.4) 21.2 (4.2, 0.3) 20.3 (2.9) 0.04 0.14
CDC criteria fulfilled (%) 88 (73) NA
NICE criteria fulfilled (%) 107 (89) NA
MFQ
Mean (SD) 17.2 (10.1) 18.7 (10.4) 6.6 (7.8) <0.001 <0.001
Disease duration months (range) 21.4 (4–104) 21.1 (6–104) NA NA NA
CFQ
Mean (SD) 19.2 (6.2) 19.9 (6.0) 8.9 (4.5) <0.001 <0.001
School absence
Mean % (SD) 65 (30) 66 (30) 2 (7) <0.001 <0.001
STAI-T
Mean (SD) 42.8 (9.0) 44.0 (9.1) 32.1 (7.25) <0.001 <0.001
KSQ
Mean (SD) 3.4 (0.97) 3.3 (0.9) 4.9 (0.86) <0.001 <0.001
CFS (CDC) subgroup: Participant subgroup that meets the CDC criteria for chronic fatigue syndrome; School absence: the percentage of days out of school during the last month
(20 days/month is 100%).
BMI, body mass index; CDC, Centers for Disease Control and Prevention; CFS, chronic fatigue syndrome; CFQ, Chalder Fatigue Questionnaire; KSQ, Karolinska Sleep Questionnaire; MFQ,
Mood and Feelings Questionnaire; NICE, National Institute for Health and Care Excellence; STAI-T, Spielberger State-Trait Inventory.




Chronic fatigue group versus
healthy controls












(95% CI) p Value d*
Difference
(95% CI) p Value d
Processing speed
CWIT condition 1+2 (s) 30.9 (6.3) 31.1 (6.5) 27.5 (5.1) 3.3 (1.1 to 5.5) 0.003 0.58 3.5 (1.2 to 5.9) 0.003 0.61
Executive function
Working memory (sum score) 14.1 (3.4) 13.7 (3.2) 16.5 (3.8) −2.4 (−3.7 to −1.1) <0.001 0.67 −2.7 (−4.1 to −1.5) <0.001 0.8
CWIT cognitive inhibition (s) 59.7 (15.2) 60.2 (15.9) 53.5 (14.0) 6.2 (0.8 to 11.7) 0.025 0.43 6.6 (0.8 to 12.5) 0.026 0.45
CWIT cognitive inhibition (errors) 2.0 (2.0) 2.0 (2.1) 1.6 (1.8) 0.4 (−0.4 to 1.1) 0.349 0.19 0.4 (−0.4 to 1.2) 0.367 0.20
CWIT cognitive flexibility (s) 67.2 (15.2) 66.1 (14.1) 62.4 (13.8) 4.8 (−0.8 to 10.4) 0.092 0.42 3.7 (−1.6 to 9.1) 0.167 0.27
Verbal learning
HVLT-R total recall (sum score) 27.2 (4.1) 27.3 (3.8) 28.9 (3.7) −1.7 (−3.2 to −0.3) 0.022 0.44 −1.6 (−3.1 to −0.2) 0.026 0.44
Verbal memory
HVLT-R delayed recall (sum score) 9.4 (2.1) 9.5 (2.1) 10.1 (1.7) −0.6 (−1.4 to 0.1) 0.119 0.33 −0.6 (−1.4 to 0.2) 0.119 0.31
BRIEF† GEC 55.1 (9.9) 55.9 (10.1) 43.8 (6.8) 11.2 (8.2 to 14.3) <0.001 1.34 12.1 (8.3 to 15.9) <0.001 1.46
*d: Cohen’s d, expressing effect size.
†BRIEF: Due to logistic problems, some BRIEF results were missing, giving a total of 32 completed responses for that inventory in the healthy controls group.
BRIEF, Behaviour Rating Inventory of Executive Function; CFS, Chronic Fatigue Syndrome; CDC, Centers for Disease Control and Prevention; CWIT, Color Word Interference Test; HVLT-R,
Hopkins Verbal Learning Test-Revised; GEC, global executive composite.
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Impaired cognitive inhibition has been reported,10 but unlike
that study we found no differences in errors for the cognitive
inhibition task. When controlling for reduced processing speed
for the cognitive inhibition task in our study, group differences
disappeared, indicating that reduced processing speed may be
the main problem and not cognitive inhibition per se. In line
with results by Haig-Ferguson et al,11 we found that the chronic
fatigue group had impaired verbal learning, but there was no
between-groups difference on delayed recall. In three Hopkins
Verbal Learning Test-Revised learning trials, we observed
impaired learning on the ﬁrst and third trials, but not on the
second trial, possibly demonstrating ﬂuctuation in working
memory. The term working memory refers to a brain system
that provides temporary storage and manipulation of the infor-
mation necessary for more complex cognitive tasks such as
learning.29 The group difference in verbal learning disappeared
when we adjusted for working memory, which may indicate that
the learning deﬁcit may be explained by the working memory
problems in our patient group.
Patients in the present study scored signiﬁcantly higher than
HC on anxiety traits and depression symptoms. When control-
ling for these two factors in the regression analyses, the group
differences in all assessed cognitive measures remained
unchanged. This is consistent with results from previous studies
showing that impaired cognitive function in adolescents with
CFS is not fully explained by depression symptoms or anxiety
traits.10 12 A similar result was reported in adult CFS patients.30
Participants with chronic fatigue reported signiﬁcantly more
sleep problems than the HC. When sleep problems were
controlled for, the signiﬁcant group differences for working
memory disappeared, indicating that impaired sleep could con-
tribute to reduced working memory. We did not observe the
same effect when controlling for sleep problems in the analysis
of processing speed, and this is in line with results from a study
on adults with CFS.31
Strengths and limitations
The relatively high number of participants is a strength of the
study. There were no missing data on the cognitive tests and few
data missing in the questionnaire responses.
Test administrators were not blinded to the participant’s
chronic fatigue or HC status, and this could have introduced
bias. Also, we did not assess the IQ of the participants; group
differences in intelligence could have confounded the group dif-
ferences in cognitive measures. On the other hand, there was no
difference between the groups regarding the parents’ highest
educational level.32 According to Lemos et al,33 parents’ educa-
tion predicts adolescents’ intelligence, so we assume that IQ is
less likely to be a confounder.
Our test protocol and testing procedure may have underesti-
mated the group differences. The quiet and structured test
environment may have caused participants to perform above
their normal capacity for everyday cognitive challenges. Use of
repeated tests or testing sessions of longer duration could
perhaps have detected effects of increasing fatigue or post-
exertional malaise, as is frequently reported by patients with
chronic fatigue.
Table 5 Multivariate analyses of the relationships between cognitive measures as dependent variables and group allocation (chronic fatigue
group vs HC), depression symptoms (MFQ), anxiety traits (STAI-T) and sleep problems (KSQ) as independent variables
Dependent variable Regression Independent variables B (95% CI) β Coefficient p Value R2
Processing speed Multivariate 1 Group 2.9 (0.4 to 5.4) 0.201 0.022 0.06
MFQ −0.04 (−0.1 to 0.06) −0.075 0.392
Multivariate 2 Group 2.9 (0.3 to 5.4) 0.200 0.027 0.06
STAI-T −0.04 (−0.2 to 0.07) −0.069 0.443
Multivariate 3 Group 3.5 (0.8 to 6.2) 0.246 0.011 0.06
KSQ −0.1 (−1.2 to 0.9) −0.023 0.807
Working memory Multivariate 1 Group −1.9 (−3.3 to −0.4) −0.220 0.011 0.10
MFQ 0.05 (−0.01 to 0.1) 0.154 0.072
Multivariate 2 Group −1.9 (−3.4 to −0.4) −0.225 0.012 0.09
STAI-T 0.05 (−0.02 to 0.1) 0.125 0.157
Multivariate 3 Group −1.5 (−3.0 to 0.1) −0.171 0.067 0.11
KSQ −0.7 (−1.3 to −0.06) −0.202 0.031
CWIT cognitive inhibition (time) Multivariate 1 Group 5.7 (−0.4 to 11.8) 0.164 0.065 0.03
MFQ −0.05 (−0.3 to 0.2) −0.034 0.701
Multivariate 2 Group 5.6 (−0.6 to 11.9) 0.161 0.079 0.03
STAI-T −0.06 (−0.3 to 0.2) −0.036 0.696
Multivariate 3 Group 5.7 (−1.0 to 12.4) 0.164 0.092 0.03
KSQ 0.3 (−2.2 to 2.9) 0.025 0.797
HVLT-R verbal learning Multivariate 1 Group −1.6 (−3.2 to 0.05) −0.169 0.057 0.03
MFQ 0.01 (−0.05 to 0.08) 0.032 0.717
Multivariate 2 Group −1.8 (−3.5 to −0.13) −0.194 0.034 0.03
STAI-T −0.01 (−0.09 to 0.07) −0.025 0.784
Multivariate 3 Group −1.9 (−3.7 to −0.15) −0.207 0.034 0.04
KSQ 0.16 (−0.5 to 0.85) 0.044 0.649
BRIEF global executive composite Multivariate 1 Group 8.6 (4.9 to 12.5) 0.360 <0.001 0.23
MFQ −0.2 (−0.35 to −0.04) −0.199 0.014
Multivariate 2 Group 7.6 (3.8 to 11.5) 0.318 <0.001 0.25
STAI-T −0.3 (−0.46 to −0.1) −0.266 0.001
Multivariate 3 Group 7.6 (3.4 to 11.8) 0.315 <0.001 0.23
KSQ 2.1 (0.5 to 3.7) 0.229 0.010
BRIEF, Behaviour Rating Inventory of Executive Function; CWIT, Color Word Interference Test; HC, healthy controls; KSQ, Karolinska Sleep Questionnaire; MFQ, Mood and Feelings
Questionnaire; STAI-T, Spielberger State-Trait Inventory.
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Lastly, as our inclusion criteria were too wide to meet pub-
lished case criteria for CFS, we advise caution in extrapolating
our ﬁndings to adolescents with CFS.
Clinical implications
We have shown group differences in processing speed, working
memory and in everyday EF in line with results from a
meta-analysis of adult CFS which concluded that performance
around 0.5–1.0 SD below HC levels is likely to impact on
day-to-day activities.34
Two thirds of the chronic fatigue group scored more than 1
SD worse than the HC or Norwegian normative data28 on the
BRIEF (see eTable 1), indicating that adolescents with chronic
fatigue demonstrate clinically signiﬁcant problems with everyday
EF.
Further, these cognitive difﬁculties may negatively affect other
cognitive functions such as verbal learning. Working memory is
often the target of cognitive training programmes because of its
assumed ability to inﬂuence a range of other cognitive pro-
cesses.35 These observations, together with impaired general EF
in everyday life, demonstrate that the problems may be clinically
relevant.
Caretakers, the health service and schools should recognise
these problems and provide neuropsychological guidance. Such
advice could include reducing the pace of teaching or work
presentation and reducing the level of distraction in the learning
environment, as suggested by Tucker et al.36 In addition,
repeated learning of new information and help structuring new
information may be useful.
Future research
Neither our study nor studies on adolescents with CFS that
have assessed cognitive function have employed repeated testing
or cognitive effort (which could resemble a classroom setting).
By using such an approach, future research could explore poten-
tial associations between cognitive impairment and post-
exertional fatigue.
Sleep problems are frequently reported concurrently with
chronic fatigue in adolescents, and the association between sleep
and cognitive problems in chronic fatigue is still unclear.
Further studies addressing cognitive problems and sleep in
chronic fatigue, possibly applying a more objective assessment
of sleep, could clarify the effect of therapeutic interventions to
improve sleep.
To our knowledge, only one study with few participants12 has
evaluated how established treatment and healthcare advice
affects cognitive performance in young people with chronic
fatigue. Further studies are needed to improve support for these
patients.
CONCLUSIONS
Adolescents aged 12–18 years with medically unexplained
chronic fatigue have impaired cognitive function on objective
cognitive tests and on measures of everyday EF compared to
HC. It is important that the health service and school teachers
address cognitive function when providing support to these
patients. Future research should evaluate treatment interventions
that can improve cognitive functioning in this patient group.
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